Biacore S200 arrives at Bio21

The Biacore S200 arrived at Bio21 Institute on Monday, 17 June 2019. This instrument, that is used to characterize molecular interactions, is one of a suite of instruments that has been funded by the Australian Cancer Research Foundation as part of the ACRF Facility for Innovative Cancer Drug Discovery. It is currently being installed and will be available soon.

Please contact Yan Hong Tan if you are interested in learning more about how you can use the Biacore S200 in your research and discovery work.